Aidigong Maternal and Child Health Co., Ltd. ('Aidigong') announced that the original deadline for the new share sale, which was scheduled for September 15, 2024, will be further extended to October 15, 2024. This extension is due to the need for the sales agent to have more time to find investors and complete the relevant administrative procedures. The share sale plan was initially announced on June 20, 2024, and detailed in a letter on July 10, with a plan to sell up to 44,350,000 new shares. According to the first supplemental agreement on August 15, the final deadline was extended from August 15 to September 15, and a second supplementary agreement was signed after the trading session on September 13, further extending it to October 15. The other terms and conditions of the share sale agreement remain unchanged. The Chairman of the company, Wang Aier, reminds shareholders and potential investors to act cautiously when buying or selling shares, as the share sale may not proceed.

Aidigong Maternal and Child Health Co., Ltd. ('Aidigong') announced that the original deadline for the new share sale, which was scheduled for September 15, 2024, will be further extended to October 15, 2024. This extension is due to the need for the sales agent to have more time to find investors and complete the relevant administrative procedures. The share sale plan was initially announced on June 20, 2024, and detailed in a letter on July 10, with a plan to sell up to 44,350,000 new shares. According to the first supplemental agreement on August 15, the final deadline was extended from August 15 to September 15, and a second supplementary agreement was signed after the trading session on September 13, further extending it to October 15. The other terms and conditions of the share sale agreement remain unchanged. The Chairman of the company, Wang Aier, reminds shareholders and potential investors to act cautiously when buying or selling shares, as the share sale may not proceed.